The Conference Board uses cookies to improve our website, enhance your experience, and deliver relevant messages and offers about our products. Detailed information on the use of cookies on this site is provided in our cookie policy. For more information on how The Conference Board collects and uses personal data, please visit our privacy policy. By continuing to use this Site or by clicking "OK", you consent to the use of cookies. 


Food as Medicine: A Path to Remission for Type 2 Diabetes

MAY 14, 2020


COVID-19 has disrupted employee routines, placing those with serious medical conditions such as diabetes and metabolic syndrome at risk. After 10 years of research and 5 published RCTs, DayTwo offers patients an effective method to treat these illnesses by using a gut microbiome profile to match the right foods to the right patient.

Using these methods, the Huntsville Hospital System was able to achieve A1C reduction, improvement in blood sugar “time-in-range,” weight loss, and cost reduction at a time when budgets are under pressure. 

Join this webcast to explore:

  • How DayTwo enabled remission for type 2 diabetes using food as medicine
  • An overview of the science, including a clinical trial at the Mayo Clinic, published in JAMA, that proved people respond differently to the same food
  • How DayTwo’s solution works, including how gut microbiome profiling creates food prescriptions to control blood sugar

Who Should Attend: This webcast is geared towards HR Benefits and Total Rewards Executives, Carrier Benefits and Clinical Staff, and Benefits/Compensation Consultants 

Support Our Work

Support our nonpartisan, nonprofit research and insights which help leaders address societal challenges.